Cargando…

Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast

Patients with functional or anatomic asplenia, including sickle cell anemia; complement component deficiency; or human immunodeficiency virus (HIV) infection have a significantly increased risk of developing meningococcal disease. The Advisory Committee on Immunization Practices (ACIP) of the Center...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Restrepo, Oscar, Clements, Diana E., Conley, Wanda J., Marshall, Gary S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147888/
https://www.ncbi.nlm.nih.gov/pubmed/36913178
http://dx.doi.org/10.1007/s40121-023-00778-1
_version_ 1785034879231066112
author Herrera-Restrepo, Oscar
Clements, Diana E.
Conley, Wanda J.
Marshall, Gary S.
author_facet Herrera-Restrepo, Oscar
Clements, Diana E.
Conley, Wanda J.
Marshall, Gary S.
author_sort Herrera-Restrepo, Oscar
collection PubMed
description Patients with functional or anatomic asplenia, including sickle cell anemia; complement component deficiency; or human immunodeficiency virus (HIV) infection have a significantly increased risk of developing meningococcal disease. The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) recommends vaccination with a quadrivalent meningococcal conjugate vaccine against serogroups A, C, W, and Y (MenACWY) for individuals 2 months of age or older who are diagnosed with functional or anatomic asplenia, complement component deficiency, or HIV infection. Vaccination with a meningococcal vaccine against serogroup B (MenB) is also recommended for individuals 10 years of age or older who are diagnosed with functional or anatomic asplenia or complement component deficiency. Despite these recommendations, recent studies have shown that vaccination coverage in these populations is low. In this podcast, the authors discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease and discuss strategies to increase coverage. Suboptimal vaccination rates could be addressed by better educating healthcare providers about recommendations for MenACWY and MenB vaccines in individuals at increased risk, increasing awareness of low vaccination coverage, and tailoring the education to the needs of particular healthcare providers and their respective patient populations. Barriers to vaccination could also be removed by administering vaccines at alternative sites of care, bundling preventative services, and implementing vaccination reminder systems that are tied to immunization information systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40121-023-00778-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-10147888
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-101478882023-04-30 Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast Herrera-Restrepo, Oscar Clements, Diana E. Conley, Wanda J. Marshall, Gary S. Infect Dis Ther Commentary Patients with functional or anatomic asplenia, including sickle cell anemia; complement component deficiency; or human immunodeficiency virus (HIV) infection have a significantly increased risk of developing meningococcal disease. The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) recommends vaccination with a quadrivalent meningococcal conjugate vaccine against serogroups A, C, W, and Y (MenACWY) for individuals 2 months of age or older who are diagnosed with functional or anatomic asplenia, complement component deficiency, or HIV infection. Vaccination with a meningococcal vaccine against serogroup B (MenB) is also recommended for individuals 10 years of age or older who are diagnosed with functional or anatomic asplenia or complement component deficiency. Despite these recommendations, recent studies have shown that vaccination coverage in these populations is low. In this podcast, the authors discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease and discuss strategies to increase coverage. Suboptimal vaccination rates could be addressed by better educating healthcare providers about recommendations for MenACWY and MenB vaccines in individuals at increased risk, increasing awareness of low vaccination coverage, and tailoring the education to the needs of particular healthcare providers and their respective patient populations. Barriers to vaccination could also be removed by administering vaccines at alternative sites of care, bundling preventative services, and implementing vaccination reminder systems that are tied to immunization information systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40121-023-00778-1) contains supplementary material, which is available to authorized users. Springer Healthcare 2023-03-13 2023-04 /pmc/articles/PMC10147888/ /pubmed/36913178 http://dx.doi.org/10.1007/s40121-023-00778-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Commentary
Herrera-Restrepo, Oscar
Clements, Diana E.
Conley, Wanda J.
Marshall, Gary S.
Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast
title Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast
title_full Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast
title_fullStr Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast
title_full_unstemmed Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast
title_short Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast
title_sort expert perspectives on the vaccination of individuals who are at increased risk of meningococcal disease due to medical conditions: a podcast
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147888/
https://www.ncbi.nlm.nih.gov/pubmed/36913178
http://dx.doi.org/10.1007/s40121-023-00778-1
work_keys_str_mv AT herrerarestrepooscar expertperspectivesonthevaccinationofindividualswhoareatincreasedriskofmeningococcaldiseaseduetomedicalconditionsapodcast
AT clementsdianae expertperspectivesonthevaccinationofindividualswhoareatincreasedriskofmeningococcaldiseaseduetomedicalconditionsapodcast
AT conleywandaj expertperspectivesonthevaccinationofindividualswhoareatincreasedriskofmeningococcaldiseaseduetomedicalconditionsapodcast
AT marshallgarys expertperspectivesonthevaccinationofindividualswhoareatincreasedriskofmeningococcaldiseaseduetomedicalconditionsapodcast